Evidence map›Paper›PMID 35713587›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2022

The hypoxia-induced changes in miRNA-mRNA in RNA-induced silencing complexes and HIF-2 induced miRNAs in human endothelial cells.

Adrianna Moszyńska, Maciej Jaśkiewicz, Marcin Serocki, Aleksandra Cabaj, David K Crossman, Sylwia Bartoszewska, Magdalena Gebert, Michał Dąbrowski, James F Collawn, Rafal Bartoszewski

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Predictive Value of PreoperativeInternational journal of molecular sciences · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Old drugs, new challenges: reassigning drugs for cancer therapies.Cellular & molecular biology letters · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Adrianna MoszyńskaDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.
Maciej JaśkiewiczDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.
Marcin SerockiDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.
Aleksandra CabajLaboratory of Bioinformatics, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland.
David K CrossmanDepartment of Genetics, The UAB Genomics Core Facility, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Sylwia BartoszewskaDepartment of Inorganic Chemistry, Medical University of Gdansk, Gdansk, Poland.
Magdalena GebertDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.
Michał DąbrowskiLaboratory of Bioinformatics, Nencki Institute of Experimental Biology of the Polish Academy of Sciences, Warsaw, Poland.
James F CollawnDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Rafal BartoszewskiDepartment of Biology and Pharmaceutical Botany, Medical University of Gdansk, Gdansk, Poland.ORCID 0000-0002-2864-6757
Gdańsk Medical University · PLInstytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLUniversity of Alabama at Birmingham · US

Funding

UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AMIT GAGGAR · 2007 to 2026
$23.0M
Cell Biology of CFTR in Polarized EpitheliaR01DK060065 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI COLLAWN, JAMES F. · 2003 to 2013
$3.1M
NIDDK NIH HHS P30 DK072482NIDDK NIH HHS R01 DK060065
6 · The paper itself

Abstract

The cellular adaptive response to hypoxia relies on the expression of hypoxia-inducible factors (HIFs), HIF-1 and HIF-2. HIFs regulate global gene expression changes during hypoxia that are necessary for restoring oxygen homeostasis and promoting cell survival. In the early stages of hypoxia, HIF-1 is elevated, whereas at the later stages, HIF-2 becomes the predominant form. What governs the transition between the two HIFs (the HIF switch) and the role of miRNAs in this regulation are not completely clear. Genome-wide expression studies on the miRNA content of RNA-induced silencing complexes (RISC) in HUVECs exposed to hypoxia compared to the global miRNA-Seq analysis revealed very specific differences between these two populations. We analyzed the miRNA and mRNA composition of RISC at 2 h (mainly HIF-1 driven), 8 h (HIF-1 and HIF-2 elevated), and 16 h (mainly HIF-2 driven) in a gene ontology context. This allowed for determining the direct impact of the miRNAs in modulating the cellular signaling pathways involved in the hypoxic adaptive response. Our results indicate that the miRNA-mRNA RISC components control the adaptive responses, and this does not always rely on the miRNA transcriptional elevations during hypoxia. Furthermore, we demonstrate that the hypoxic levels of the vast majority of HIF-1-dependent miRNAs (including miR-210-3p) are also HIF-2 dependent and that HIF-2 governs the expression of 11 specific miRNAs. In summary, the switch from HIF-1 to HIF-2 during hypoxia provides an important level of miRNA-driven control in the adaptive pathways in endothelial cells.

Indexed as

MicroRNAsRNA-Induced Silencing ComplexBasic Helix-Loop-Helix ProteinsCell HypoxiaEndothelial CellsEndothelial PAS Domain-Containing Protein 1HumansHypoxiaHypoxia-Inducible Factor 1, alpha SubunitRNA, MessengerBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1Hypoxia-Inducible Factor 1, alpha SubunitMicroRNAsRNA-Induced Silencing ComplexRNA, MessengerEPAS1HIF1AHIF-1αHIF-2α

Identifiers

PMID35713587
PMCPMC9220987
OpenAlexW4283067167

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.